Subscribe to NRx Newsletter

Events

Upcoming Events

Past Events
 Thursday, March 21, 2024
 11:00am - 11:30am EDT
 Monday, February 26, 2024
 2:30pm - 3:00pm EST

Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals, will present a corporate overview at the BIO CEO & Investor Conference, which is scheduled to take place February 26-27, 2024, at the Marriott Marquis in New York City. Presenting with him will be Matthew Duffy, the newly-appointed co-CEO of HOPE Therapeutics.

Concurrent with the presentation, NRx plans to file a proxy statement, subject to board approval, for Nasdaq:NRXP shareholders outlining the share structure and seeking a shareholder advisory vote to support the planned share dividend for HOPE Therapeutics.

Presentation Date: Monday, February 26th, 2024
Time: 2:30 PM ET
Location: The Royale Room, Marriott Marquis, New York City
Registration: https://bcic.bio.org/registration

 Monday, January 8, 2024 -
Wednesday, January 10, 2024
 8:00am - 6:00pm PST
  Venue Beacon Grand Hotel
San Francisco, CA

NRx Pharmaceuticals (NRXP) will be participating in-person at the LifeSci Partners Corporate Access Event for three days from January 8th through the 10th in San Francisco.

2024 promises to be a year of substantial growth that will include the filing of the Company’s first New Drug Application. We would welcome the opportunity to update you on our extraordinary recent progress, upcoming clinical and regulatory catalysts, and to answer your questions. Sign-up: LifeSci Partners Corporate Access Event 2024 

 Sunday, January 7, 2024

NRx Pharmaceuticals, Inc. gave the keynote address entitled "Ketamine for Suicidal Depression: The Benefits are Clear, But So are the Risks," at the Sachs Neuroscience Innovation Forum at the Marines' Memorial Club in San Francisco, CA on January 7, 2024.

Watch the keynote address here.

Read the keynote address transcript here.

 Tuesday, December 19, 2023
 11:00am - 12:00pm EST

The Annual Meeting will be conducted in a virtual-only format. You will be able to attend the Annual Meeting virtually, vote your shares, and submit your questions during the meeting.

 Monday, December 4, 2023
 4:30pm - 4:55pm EST


Dr. Jonathan Javitt, Founder and Chief Scientist of NRx Pharmaceuticals, will present a corporate overview at the Noble Capital Markets’ 19th Annual Emerging Growth Investor Conference on Monday, December 4th, 2023, at the College of Business Executive Education Building at Florida Atlantic University in Boca Raton, Fla.

 Tuesday, November 14, 2023
 4:30pm - 5:30pm EST
 Thursday, October 12, 2023
 4:00pm - 4:25pm EDT
  Venue Wyndam Grand Jupiter at Harbourside Place
Jupiter, Florida

Dr. Jonathan Javitt, Chief Scientist of NRx Pharmaceuticals, will present a corporate overview. Management will conduct in-person one-on-one meetings throughout the conference and deliver the Company's presentation.

 Tuesday, September 12, 2023
 5:00pm - 6:00pm EDT
Corporate Presentation

Click here to view our corporate presentation or on the image below

Bottom Global Links (above footer)